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Traumatic brain injury (TBI) is a complex disease to study due to the multifactorial injury
cascades occurring after the initial blow to the head. One of the most vital players in
this secondary injury cascade, and therapeutic target of interest, is the mitochondrion.
Mitochondria are important for the generation of cellular energy, regulation of cell death,
and modulation of intracellular calcium which leaves these “powerhouses” especially
susceptible to damage and dysfunction following traumatic brain injury. Most of the
existing studies involving mitochondrial dysfunction after TBI have been performed in
male rodent models, leaving a gap in knowledge on these same outcomes in females.
This mini-review intends to highlight the available data on mitochondrial dysfunction
in male and female rodents after controlled cortical impact (CCI) as a common model
of TBI.
Keywords: bioenergetics, oxidative stress, glucose utilization, sex hormone influence, CNS injury
INTRODUCTION
Clinical Overview of Sex Differences in Traumatic Brain Injury
Traumatic brain injury (TBI) occurs from a primary bump, blow, jolt, or penetrating injury to the
head that disrupts brain function. TBI is a continuously growing health concern as the most recent
CDC data from 2019 showed 61,000 TBI-related deaths in the US (Centers for Disease Control
and Prevention, 2020). Following the primary impact on the head, there are complex biochemical,
cellular, and molecular secondary injury cascades that cause, ischemia, excitotoxicity, cerebral
swelling, inflammation, and diffuse axonal injury (Kochanek et al., 2000). In humans, TBI can
be classified as mild, moderate, or severe depending on the clinical presentation of neurological
symptoms including Glasgow Coma Scale (GCS) score, headache, dizziness, loss of consciousness,
seizures, coma, or even death and these symptoms vary from person to person.
Gupte et al. (2019) nicely summarized the available data on the reported outcomes in males vs.
females in human and animal TBI studies. One of the main takeaway points from that review was
that a larger percentage of the total human studies reported women faring worse thanmen after TBI,
conversely, a larger percentage of the total rodent studies reported females having better outcomes
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than males. However, when the human and rodent data were
separated by injury severity (mild-moderate-severe), a larger
percentage of studies reported both women and females had
better outcomes than men/males after a more severe injury,
but results after mild TBI are less conclusive. Data assessing
outcomes after mild TBI showed a higher percentage of studies
reported women experienced worsened outcomes and females
had mixed results compared to their male counterparts (Gupte
et al., 2019). The authors summed up that sex differences
in TBI can be considered a ‘‘mosaic’’ where women/females
have better outcomes in certain measures and men/males have
better outcomes in others, driving home the importance of
studying both sexes. The 2016 CDC TBI Surveillance Report
identified males having significantly higher age-adjusted rates
of TBI-related hospitalization compared to females, but the
highest number of hospitalizations occurred at age >75 years
old (Center for Disease Control and Prevention, 2021). This
sex difference may be attributed to men being more involved
in contact sports, military service, or even physical altercations
(Biegon, 2021). Further, when sex and age are considered after
moderate-severe TBI, results have shown that men between
15–50 years of age had a slightly increased survival rate over
age-matched women. However, this effect is reversed after
∼50 years of age, showing peri- and post-menopausal women
(the years around or after menopause when ovarian hormone
levels are diminishing) had increased survival over age-matched
men (Cleveland Clinic, 2019; Biegon, 2021). A conflicting study
was performed in 13,437 patients with moderate-severe TBI
in which the authors found men had similar mortality rates
as women after TBI. However, when the data is separated
by age, pre-menopausal women (<50 years old) had similar
mortality rates as age-matched men, but post-menopausal
women (≥50 years old) had reduced mortality compared to
age-matchedmales. This study concluded that ovarian hormones
present during the pre-menopausal period (e.g., estradiol
and progesterone) are not neuroprotective against TBI-related
mortality (Davis et al., 2006). The risk of TBI in the female
population is growing given the increasing number of women
serving in active military duty, and participating in competitive
sports like soccer and basketball, as well as women suffering
from intimate partner violence (IPV) who often receive severe
blows to the head (Arambula et al., 2019; Gupte et al., 2019).
Unfortunately, there are still knowledge gaps on the effects of
hormonal status at the time of injury, safety, and efficacy of
TBI interventions for women, and the importance of risk factors
associated with poor outcomes after TBI in women (Biegon,
2021). As detrimental as this disease is, there are currently no
FDA-approved pro-regenerative or neuroprotective therapeutics
for men or women after TBI, though there are currently eight
active, not recruiting and 22 recruiting interventional Phase I,
II, and III clinical trials throughout the US (NIH U.S. National
Library of Medicine, 2021a,b).
One trial of note is the 2014 Phase III clinical trial involving
progesterone as a treatment for acute TBI. This double-
blind, placebo-controlled trial was stopped for futility because
intravenous progesterone was not demonstrating improved
neuropsychological performance or higher Glasgow Coma Scale
Extended (GOSE) scores in patients with moderate-severe TBI
(Goldstein et al., 2017). Previously, progesterone treatment
showed promise in animal studies of TBI which led to an
early phase II trial with 100 patients enrolled with 77 subjects
randomized to receive intravenous progesterone and 23 to
receive placebo. Results from this early human study showed
reduced 30-day mortality in the progesterone group compared to
placebo and similar rates of adverse events between progesterone
and placebo groups, suggesting that progesterone administration
is safe and provides neuroprotective effects (Wright et al., 2007).
Progesterone was first noted as a topic of interest in 1987 by
Attella et al. (1987) who saw reduced edema in pseudopregnant
rats compared to normal-cycling rats after TBI. It was
hypothesized these observed differences were due to increased
levels of gonadal hormones during pseudopregnancy compared
to control rats (Attella et al., 1987). Failure of progesterone in the
larger clinical trial may have been due to increasing the sample
size. The review by Gupte et al. (2019) found that 53% of studies
with 0–1,000 patients reported women having worse outcomes
than men, but in studies with >10,000 patients, 67% reported
better outcomes in females than males (Wright et al., 2007).
Ultimately, the failure of progesterone, likemany other failed TBI
trials, is most likely due to the complexity and heterogeneity of
TBI, the unidimensional characterization of injury in humans,
and the limited ability to translate experimental data to human
TBI (Saatman et al., 2008; Skolnick et al., 2014). For these reasons,
it is imperative to utilize different injury models to understand
the underlying pathophysiology of TBI and ultimately translate
those findings into humans. However, this mini-review focuses
on the controlled cortical impact (CCI) model of TBI and the
effect of this injury on various mitochondrial outcomes in male
and female rodents.
Estrogen Receptors and Mitochondria
Sex differences in mitochondrial function cannot be addressed
without first discussing sex hormones and their receptors.
Unfortunately, little is known about the role of mitochondrial
progesterone receptors in the brain, though it is documented to
influencemitochondrial respiration in the heart (Dai et al., 2013).
It is typically believed both estrogen and progesterone receptors
act through genomic mechanisms to regulate mitochondria,
though the addition of estradiol directly to isolated hepatic
mitochondria was shown to reduce peroxide production and
limit mitochondrial cytochrome c release (Borrás et al., 2010).
This study suggests estradiol acts directly on mitochondrial
estrogen receptors (ERs) to protect against oxidative stress.
Within neurons, ERs have been found in the nucleus, plasma
membrane, and mitochondria, though it is unknown whether
ER action is coordinated between these compartments or if
ER signaling remains independent within these compartments
(Brinton, 2008). Evola et al. (2018) measured ERβ content in total
hippocampal and cortical mitochondria between normal, aging
male and female rats. They found no significant difference in
ERβ content between sexes in any of the age groups, though there
was a trend of females having greater ERβ content in the cortex
at 4 weeks old compared to males (Evola et al., 2018). In a rat
model of diffuse TBI, vehicle-treated OVX female rats showed
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decreased ERβ mRNA expression in the whole brain after injury
than estradiol-treated rats (Khaksari et al., 2015). Interestingly,
protein levels of ERβ were not significantly different between the
groups. Both mRNA and protein levels of ERα were significantly
increased with estradiol treatment after TBI, though TBI alone
or vehicle treatment after TBI were not different from sham
ERα mRNA or protein expressions (Khaksari et al., 2015). These
studies were only conducted in female rats after experimental
TBI though, so studies should be conducted in male rats as well
to determine if there is sexual dimorphism. Additionally, these
studies should be observed inmitochondrial fractions rather than
the whole brain to determine whether expression changes after
TBI affect mitochondrial function after injury.
Estrogen and Progesterone Influence on
Mitochondrial Bioenergetics
Notably, mitochondria are important targets of secondary injury
caused by TBI. Known as the ‘‘powerhouse’’ of the cell,
mitochondria are the primary location of ATP synthesis, but
their maintenance of cellular homeostasis drives home their
nickname. Mitochondria are responsible for regulating cell death
pathways, calcium buffering, oxidative phosphorylation, and
ATP synthesis as summarized in Figure 1A, which makes them
important targets in neurological disorders like Parkinson’s
disease, Alzheimer’s disease, TBI, and stroke (Yonutas et al.,
2016). A study by Gaignard et al. (2015) found gonadal status
influences mitochondrial function in female mice, but not
males. Ovariectomy (OVX) impaired coupled and maximal
NADH-linked respiration after addition of pyruvate + ADP
and the uncoupler m-Cl-CCP in isolated brain mitochondria
compared to intact females; however, castration in male mice did
not impair oxygen consumption rates compared to intact males
(Gaignard et al., 2015). Additionally, intact females had higher
coupled and maximum NADH-linked respiration compared
to intact males, but OVX knocked these rates down to male
levels (Gaignard et al., 2015). This study indicates female
sex hormones, not male hormones, affect brain mitochondrial
respiratory function, making it an important topic to study
in the scope of TBI. To determine the role of estrogen
(30 µg/kg) and progesterone (30 µg/kg) on isolated whole
brain mitochondria from uninjured, OVX rats, Irwin et al.
(2008) measured bioenergetic function by respiratory control
ratio (RCR) after a single in vivo exposure. RCR is defined by
dividing State III (coupled respiration after addition of ADP) by
State IV (proton leak after addition of ATP synthase inhibitor,
oligomycin) respiration to determine mitochondrial coupling of
the electron transport system to oxidative phosphorylation and
general mitochondrial health. They found in vivo progesterone
treatment alone gave a 24.5% increase in mitochondrial RCR
and estradiol gave a 13.4% increase in RCR, both compared
to mitochondria from vehicle-treated rats (Irwin et al., 2008).
This study was performed in naïve, uninjured rats, but shows
the presence or absence of female sex hormones affects
mitochondrial bioenergetic function.
The studies mentioned previously in this section were
performed in mitochondria isolated from uninjured animals;
now we’ll shift focus to studies analyzing bioenergetics in
brain mitochondria isolated from rodents that have received
controlled cortical impact (CCI) injury. CCI is a model of
TBI which applies a mechanical force directly to the exposed
cortex by a pneumatic piston or electromagnetic actuator
creating morphologic, cerebrovascular, and neurobehavioral
impairments similar to those observed in humans (Osier and
Dixon, 2016; Yonutas et al., 2016). Greco et al. (2020) aimed
to determine how cerebral metabolic state influences substrate
metabolism after severe CCI in male and female rats. The
authors measured State III, State IV, and State V (maximum
respiration after addition of themitochondrial uncoupler, FCCP)
respiration, as well as the RCR in mitochondria isolated from the
ipsilateral peri-contusional cortex. They administered different
metabolic substrates [glucose, lactate, β-hydroxybutyrate (BHB)]
in the hyper- (0–3 h post-injury; early administration) or
hypo-glycolytic (6–9 h post-injury; late administration) state
and measured the effects on bioenergetic activity. Male rats
showed reduced State III respiration and reduced RCR 24-h
post-severe CCI compared to sham. The female rats showed
reduced State III and State V respiration, however, RCR
was not significantly different from sham, meaning general
mitochondrial bioenergetic health was not impaired by the
injury. Overall, it was shown that late lactose provided benefit
in both males and females while interestingly, early BHB was
beneficial to male mitochondria after injury, but early and late
BHB administration impaired female mitochondrial function
(Greco et al., 2020). This may be due to estrogen’s role in
promoting glucose utilization and mitochondrial bioenergetic
function as reported in healthy neurons, preventing the shift to
alternative fuel sources and hypometabolism seen in Alzheimer’s
Disease, though this has yet to be fully addressed after TBI
(Brinton, 2008). In all, one important finding from this study was
that the normal cycling female rats did not have impaired RCR
after severe CCI, which may indicate cycling ovarian hormones
play a protective role in maintaining mitochondrial health after
injury, though this has yet to be replicated or examined further.
A study by Robertson et al. (2006) looked at the effects of
progesterone treatment on mitochondrial function in female
ovariectomized (OVX) rats after moderate-severe CCI. They
found that 1 h after injury, mitochondria from the progesterone
group (25 ng/ml) had restored RCR to sham levels compared
to injured-vehicle control (Robertson et al., 2006). Interestingly,
this study saw reduced RCR after injury compared to sham, an
effect not seen by Greco et al. (2020) suggesting this injury effect
is present after elimination of ovarian hormones by OVX. The
effect of progesterone was further studied in male and female
rat models of pediatric TBI by the same group (Robertson and
Saraswati, 2015). They found progesterone treatment after CCI
improved mitochondrial RCR compared to vehicle-treated male
pups. This reduction came from decreased State IV respiration
as there was no change in State III respiration between the
groups. In the female pups, however, there were no significant
alterations in State III, State IV, and RCR in the progesterone- or
vehicle-treated female pups after CCI than the normal, uninjured
pups (Robertson and Saraswati, 2015). This study suggested
progesterone may be applied for the treatment of pediatric TBI,
though progesterone treatment failed to provide benefits in
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adults after TBI (Robertson and Saraswati, 2015; Goldstein et al.,
2017).
Testosterone Effect on Mitochondrial
Bioenergetics After CCI
Although most mitochondrial research utilizes male models of
TBI, there is little known about the influence of testosterone
(TS) on mitochondrial bioenergetics after injury. TS deprivation
in castrated male rats was shown to impair mitochondrial gene
expression in the hippocampus, which suggests genomic action
of TS plays a role in maintaining normal mitochondrial function
(Hioki et al., 2014). A study by Carteri et al. (2019) hypothesized
that mitochondrial dysfunction is influenced by the reduction
of brain TS levels after injury and that supplementation of TS
would improve mitochondrial function. The authors observed
improved mitochondrial bioenergetics in the whole cortex of
male mice treated with testosterone (TS) compared to the vehicle
after severe CCI (Carteri et al., 2019). TS was administered 24 h
after CCI and ex vivo cortical mitochondrial analyses occurred
at 10-days post-CCI. They found mitochondrial membrane
potential was significantly elevated at baseline compared to
sham but was restored to sham levels by TS administration.
Membrane potential is a large driver of mitochondrial action,
so the authors then looked at the effect of TS administration
on oxidative phosphorylation (OxPHOS) after CCI. State
III respiration (pyruvate, malate, glutamate, and ADP) was
significantly decreased in the injured-vehicle mice compared to
injured-TS and vehicle-shammice. MaximumOxPHOS through
complex-I and II activation after addition of State III substrates,
succinate, and saturating ADP was also reduced in injured-
vehicle mice compared to vehicle-sham and injured-TS mice.
The authors concluded TS treatment after CCI maintained
mitochondrial bioenergetic function to promote cell survival,
though this has yet to be explored by other groups (Carteri et al.,
2019).
Excitotoxicity, Oxidative Stress, and Lipid
Peroxidation
The brain requires a lot of energy to maintain normal neuronal
function, so this high metabolic demand needs to be fulfilled by
mitochondria and oxygen supply, making neurons sensitive to
mitochondrial oxidative damage (Irwin et al., 2008). Following
TBI, several secondary injury mechanisms occur including
excitotoxicity and oxidative stress. In short, after the initial
injury, there is increased excitotoxic glutamate that binds to
AMPA and NMDA receptors causing an influx of calcium to the
neuron. Mitochondria are responsible for sequestering calcium,
however, eventually, the load becomes too much and further
contributes to the excitotoxic event. Mitochondrial membrane
potential decreases to dangerous levels (100–120 mV) ramping
up the ETC to restore membrane potential to healthy levels
(180 mV), but in doing so, increases the propensity for electron
slippage and reactive oxygen and nitrogen species (ROS/RNS)
production. If the membrane potential gets too low, the ATP
synthase will start consuming ATP. Eventually, the membrane
potential is so low that the mitochondrial permeability transition
pore (mPTP) opens and releases proteins like cytochrome c to
signal for apoptosis (Yonutas et al., 2016). Radical production
damages lipid membranes by reacting with polyunsaturated fatty
acids in a process known as lipid peroxidation, a well-established
contributor to TBI neuropathology (Hill et al., 2020).
Borrás et al. (2003) have shown synaptic and non-synaptic
brain mitochondria isolated from intact female rats generate less
hydrogen peroxide than intact males and ovariectomized (OVX)
females. Hepatic mitochondria from OVX rats administered
daily with 17β-estradiol (1 µg/kg body weight) had peroxide
levels that were not statistically different from intact female
mitochondria; it was shown this antioxidant effect of estradiol
correlated with higher glutathione levels (Borrás et al., 2003).
These studies were not performed in brain mitochondria, though
it shows proof of principle that estrogen has antioxidant effects
on hepatic mitochondria (Borrás et al., 2003). It has been shown
in male models of TBI that injury increases mitochondrial
reactive oxygen species (ROS) production (Kumar Sahel et al.,
2019; Greco et al., 2020). A study by Greco et al. (2020) also
showed increased peroxide production 24 h post-CCI in male
rats consistent with previous data; though notably there was no
difference in injured female peroxide production compared to
sham. Robertson and Saraswati (2015) reported progesterone
(10 mg/kg) administration 1 h post-CCI did not prevent the
injury-induced decrease in glutathione in brain mitochondria
isolated from female rats but did prevent this decrease in males.
Notably, mitochondria from uninjured females had significantly
higher glutathione levels than uninjured males. This study,
however, was performed in a pediatric model of CCI though
it indicated progesterone administration after an injury is not
neuroprotective against oxidative stress in adolescent females,
but may benefit males (Robertson and Saraswati, 2015). A study
by Carteri et al. (2019) showed testosterone (TS) administration
reduced baseline cortical peroxide production after CCI relative
to sham levels compared to the vehicle-treated injured mice.
However, the rate of peroxide production from TS-treated mice
was elevated relative to sham after various respiratory substrate
administrations, indicating TS does not completely prevent
mitochondrial peroxide production after CCI. Additionally, the
injured-vehicle mice had elevated total ROS levels compared
to injured-TS and vehicle-sham mice (Carteri et al., 2019).
These studies indicate endogenous female hormones present
during the impact and testosterone administration after the
impact may provide neuroprotection from oxidative stress
in rodents.
A clinical study assessing excitotoxic glutamate levels in men
and women after severe TBI found men had elevated cerebral
spinal fluid (CSF) glutamate levels during every 12 h observation
period after injury (0–12, 12–24, 24–36, and 36–48 h after
injury; Wagner et al., 2005). CSF glutamate remained low in
the female group during the first interval, peaked in the second
interval above males, and continuously decreased until 48 h.
The authors suggested this was due to estrogen attenuation of
NMDA-mediated calcium activity in response to the excitotoxic
glutamate levels seen after severe TBI, though they agreed this
relationship needed to be further addressed (Wagner et al.,
2005). Another study observed the lipid peroxidation marker F2-
isoprostane in human CSF after severe TBI found women had
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TABLE 1 | Summary of literature in sex differences in mitochondrial dysfunction following TBI.
Summary of Sex Differences in Mitochondrial Bioenergetic Function after TBI
Reference Species (Age; Alteration) TBI Model and Severity Male Result Female Result
Greco et al. (2020) Rat (adult) CCI; severe (2 mm depth) Decreased State III respiration
and RCR compared to sham.
Decreased State III and State V
respiration, but no change in RCR
compared to sham.
Robertson et al. (2006) Rat (adult; OVX) CCI; moderate-severe
(1.5 mm depth)
- Progesterone (25 ng/ml) improved
RCR after CCI relative to sham.
Robertson and Saraswati
(2015)
Rat (PND 17–21) CCI; moderate-severe
(1.5 mm depth)
Progesterone (10 mg/kg)
improved RCR after CCI similar
to sham.
CCI did not significantly reduce
RCR compared to sham;
progesterone treatment did not
significantly improve RCR
compared to the other groups.
Carteri et al. (2019) Mouse (adult) CCI; severe (2 mm depth) Testosterone (15 mg/kg)
improved State III respiration
(CI) and maximum OxPHOS
after CCI similar to sham;
Testosterone improved ∆Ψm
after CCI similar to sham.
-
CCI = controlled cortical impact; State III respiration = glutamate, malate, and ADP (Greco et al., 2020), pyruvate, malate, glutamate, and ADP (Carteri et al., 2019);
RCR = (State III/State IV respiration) a general marker of mitochondrial health and coupling ability; OxPHOS = Carteri et al., 2019 defined it as maximal oxidative
phosphorylation capacity after additions of pyruvate, malate, glutamate, and succinate in the presence of saturating ADP; ∆Ψm = mitochondrial membrane potential.
Summary of Sex differences in Mitochondrial Excitotoxicity, Oxidative Stress, and Lipid Peroxidation After TBI
Reference Species (Age; Alteration) TBI Model and Severity Male Result Female Result
Greco et al. (2020) Rat (adult) CCI; severe (2 mm depth) Increased peroxide production
after CCI similar to sham.
No change in peroxide production
after CCI compared to sham.
Robertson and Saraswati
(2015)





compared to uninjured control;
uninjured male mitochondria
had significantly lower levels of
glutathione than uninjured
female mitochondria.
Progesterone did not prevent
CCI-induced glutathione reduction
in brain mitochondria after injury
compared to uninjured control;
mitochondria from uninjured
females had higher glutathione
levels than that of uninjured males.
Carteri et al. (2019) Mouse (adult) CCI; severe (2 mm depth) Testosterone (15 mg/kg)
improved baseline peroxide





administrations, but was still
increased compared to sham;
Testosterone reduced total
ROS levels similar to sham.
-
CCI = controlled cortical impact; ROS = reactive oxygen species; GCS = Glasgow Coma Scale; CSF = cerebrospinal fluid.
Summary of Sex Differences in Glucose Metabolism after TBI
Reference Species (Age; Alteration) TBI Model and Severity Male Result Female Result
Greco et al. (2020) Rat (adult) CCI; severe (2 mm depth) Exogenous glucose
administration during both the
hyper- and hypometabolic
states after CCI worsened
mitochondrial RCR similar to
vehicle CCI.
Exogenous glucose administration
during hypometabolic state after
CCI worsened mitochondrial RCR
compared to sham and vehicle CCI;
No significant impairment in RCR
with glucose administration during
hypermetabolic state similar to
sham and vehicle CCI.
CCI = controlled cortical impact; RCR = (State III/State IV respiration) a general marker of mitochondrial health and coupling ability; hypermetabolic state = 0–3 h post-CCI;
hypometabolic state = 6–9 h post-CCI (Greco et al., 2020).
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FIGURE 1 | Summary of traumatic brain injury-induced mitochondrial
disruptions compared to their normal functions and what we know so far
about sex-specific differences in these disruptions. (A) Normal mitochondrial
function is disrupted after traumatic brain injury (TBI). (B) The well-known
consequences of TBI such as impaired mitochondrial bioenergetics,
increased reactive oxygen species (ROS), increased excitotoxicity and lipid
peroxidation, and impaired glucose metabolism have been established in
male models of injury. The few studies addressing these in female models
have shown increased bioenergetics, reduced ROS, increased acute
glutamate levels, and reduced lipid peroxidation, though glucose metabolism
is still unclear compared to males.
markedly lower F2-isoprostane levels compared to men (Bayir
et al., 2004). These studies highlight the observed sex differences
in oxidative stress seen in the clinic and reveal antioxidant effects
of female sex hormones (i.e., estrogen and progesterone) in these
outcomes.
Glucose Utilization After TBI
The brain has high metabolic demand and preferentially utilizes
glucose for energy, so glucose availability is vital for normal brain
function. Cerebral autoregulation maintains normal cerebral
blood flow(CBF) across a range of blood pressures to ensure
sufficient oxygen and glucose can get to their destinations.
Cerebral autoregulation is impaired after TBI causing CBF to
decrease, which often leads to poor patient outcomes making
this one of the important targets for therapeutic intervention
following TBI (Roof and Hall, 2000; Jalloh et al., 2015; Armstead
and Vavilala, 2019). It was found that cerebral glucose utilization
in some brain regions, including the hippocampus, varied with
the phases of the estrus cycle in uninjured, normal cycling female
rats compared to male rats (Nehlig et al., 1985). It has also been
shown that adult females have greater CBF than age-matched
males; CBF diverges in the sexes around mid-puberty when
estrogen levels rise in females, but CBF eventually drops to male
levels around the age of 65 years old, around/after menopause
when female hormone levels are low (Aanerud et al., 2017;
Prins, 2017). This suggests glucose utilization in the brain is
influenced by female sex steroids and would be an important
topic to study after TB (Prins, 2017). Studies performed in young
(∼20 years old) male and female athletes with and without
a history of concussion (HOC) showed men with HOC had
significantly lower CBF than men without HOC. There was no
significant difference between CBF of women with or without
HOC; however, women who received multiple concussions had
lower CBF than women who only received one (Hamer et al.,
2020).
Following rodent TBI, there is an initial hypermetabolic state
that involves increased extracellular potassium, glutamate, and
calcium accumulation, which drives increased glucose utilization
in the brain (Greco et al., 2020). The hypometabolic state
occurs about 6 h post-injury in rats and the duration of this
phase often varies with injury severity. The hypometabolic
state is associated with decreased glucose utilization and
mitochondrial dysfunction from altered ionic flux (Greco
et al., 2020). Estrogen has been shown to play a role in
promoting glucose utilization by facilitating glucose transport
and increasing the expression or activity of key enzymes
involved in glycolysis and the tricarboxylic acid (TCA) cycle
(i.e., pyruvate dehydrogenase complex subunits, hexokinase,
phosphofructokinase) in healthy neurons through activation
of nuclear, plasma membrane-bound, and/or mitochondrial
estrogen receptors (ERs; reviewed in Brinton, 2008). However,
administration of exogenous glucose during the hypometabolic
phase (6–9 h post-CCI) resulted in worsened mitochondrial
respiratory control ratio (RCR) after severe CCI in both male
and female rats, but administration of glucose during the
hypermetabolic (0–3 h post-CCI) only worsened RCR in male
rats after injury. The authors of this study hypothesized that
females did not appear to be as metabolically impaired as males
after the addition of glucose because it may not be considered
a ‘‘stressor’’ in the females like it might be in the males
after injury (Greco et al., 2020). Alternatively, administration
of β-hydroxybutyrate (BHB) during the hypometabolic period
increased mitochondrial respiration and Acetyl CoA content
in injured males but had detrimental effects in females
indicating the switch to ketone bodies as a fuel source may
be harmful to female metabolic recovery after TBI. However,
female cerebral metabolism has yet to be fully characterized
after TBI.
DISCUSSION AND CONCLUSION
There is limited overlap in available data regarding sex
differences in traumatic brain injury and data on the effects of
various sex hormones on mitochondrial function (see Table 1).
To better understand the complex nature of female outcomes
after TBI, it is vital to study the role of mitochondria.
Mitochondria are important regulators of cellular homeostasis,
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calcium handling, and energy production so they are important
therapeutic targets of interest to prevent further damage after
injury.Most of what we know aboutmitochondrial bioenergetics,
oxidative stress, and glucose utilization following TBI was
studied in males, so to fill the gaps we need to conduct these
experiments in female models, as well. This mini-review presents
the available data utilizing the control cortical impact (CCI)
model, summarized in Table 1 and Figure 1B, and hopefully
reveals the gaps in knowledge we as scientists need to address
in the field of mitochondria and TBI to be able to study and
treat both males and females effectively. It is hypothesized
that these mitochondrial changes represented in Figure 1B
are influenced by female ovarian hormones (i.e., estrogen and
progesterone) and testosterone, which is summarized by the
studies in Table 1. One limitation in this field is the failure to
apply other methods to model TBI for mitochondrial analyses
in both sexes. Other injury mechanisms like a blast injury,
weight drop injury, or rotational injury can be utilized to mimic
the heterogeneity seen in the human TBI population; these
injuries can then be applied to better understand mitochondrial
dysfunction in both sexes (Saatman et al., 2008; Yonutas et al.,
2016).
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